A Robust Chromatographic Method for Drug Release profiling of liposomal doxorubicin HCl.

Liposomes are excellent drug delivery vehicles for chemotherapeutics as they may change the pharmacokinetics of therapeutic compounds, resulting in altered tissues distribution, and in some cases, reduced cytotoxicity and enhanced distribution and efficacy of the active pharmaceutical ingredient (API) at target tissues. Drug release profiles of liposomal formulations are crucial to support equivalence evaluation and quality control in pre- and post-approval stages. We developed an automated chromatographic method for quantifying the drug release profile of liposomal formulations containing doxorubicin to overcome the shortcomings of currently available methods. The newly developed method employs nanoparticle exclusion chromatography (nPEC), using a monolithic silica column coated with polyvinylpyrrolidone to separate the released drug from liposomal encapsulated drug. We evaluated the effects of pH, temperature, and ammonium formate concentration on the drug release rate. The optimized release buffer consisting of 5 % sucrose, 20 mM l-histidine, and 200 mM ammonium formate was selected for the drug release profiling of five liposomal formulations at 47 °C. The drug release profiles of five liposomal doxorubicin formulations were similar. Our automated method requires very small amounts of the sample and provides release profiles with high sensitivity and accuracy. In addition, this method can be applied to other liposomal products to allow for simple, fast, and accurate analysis of in vitro drug release profiling.

An Automated Capillary Electrophoresis Based Method for Drug Release Profiling of Liposomal Doxorubicin.

Liposomal doxorubicin hydrochloride is an antineoplastic agent widely used against human cancers. The data from in vitro drug release test (IVRT) is essential for quality and/or bioequivalence evaluation in drug approval and post-approval regulation of liposomal drug products. However, most of the currently available IVRT methods for liposomal doxorubicin hydrochloride have experimental deficiencies associated with liposomal rupture during the separation process which is needed for selective quantification of released drug from liposomal-bound drug. In addition, many of the methods are time consuming, requiring bulk quantities of liposomal drug product, and lack of automation. We have developed a selective, sensitive, and automated capillary electrophoresis (CE)-based IVRT method, measuring released doxorubicin without additional sampling and separation steps. This method requires a small volume of sample compared to currently available methods. The IVRT release study with liposomal doxorubicin was conducted at different temperatures and pH conditions. It was observed that the release profiles obtained for five formulations including the reference listed drug were similar at pH 6.50 and 47.0 °C. The drug release increased with the increase of media pH and temperature. Complete doxorubicin release (100 %) was obtained in 7 h at pH 6.50 and 47.0 °C, and in less than 3 h at pH 6.50 and 52.0 °C. This CE-based method can be extended for determination of the IVRT profiling of other liposomal drug products.

N-Substituted Auxiliaries for Aerobic Dehydrogenation of Tetrahydro-isoquinoline: A Theory-Guided Photo-Catalytic Design.

Visible-light mediated aerobic dehydrogenation of N-heterocyclic compounds is a reaction with enormous potential for application. Herein, we report the first complete aerobic dehydrogenation pathway to large-scale production of isoquinolines. The discovery of this visible light photoredox reaction was enabled through the combination of mathematical simulations and real-time quantitative mass spectrometry screening. The theoretical calculations showed that hyper-conjugation, the main underlying factor hindering the aerobic oxidation of tetrahydroisoquinolines, is relieved both by π- and σ-donating substituents. This mechanistic insight provided a novel photocatalytic route based on N-substituted auxiliaries that facilitated the conversion of tetrahydroisoquinolines into the corresponding isoquinolines in just three simple steps (yield 71.7% in bulk-solution phase), using unmodified Ru(bpy)3Cl2 photocatalyst, sun energy, atmospheric O2, and at ambient temperature.

Highly efficient metal(iii) porphyrin and salen complexes for the polymerization of rac-lactide under ambient conditions.

Ligated metal(iii) complexes, Al(iii), In(iii), Cr(iii), and Co(iii), containing tetraphenylporphyrin (TPP) and cyclohexylsalen (Cy-salen) ligands were investigated for the polymerization of rac-lactide (rac-LA). A combination of metal complexes, co-catalyst, and co-initiator was shown to be highly efficient for the ring-opening polymerization of rac-LA at room temperature. Influences of metal centers, ligands, and co-catalysts were investigated. Higher Lewis acidity of metal centers and ligands enhanced catalytic activity. Ionic co-catalysts showed increased polymerization rates. Polymerization of rac-LA catalyzed by tetraphenylporphyrin aluminum chloride ((TPP)AlCl) and bis(triphenylphosphine)iminium chloride (PPN+Cl-) in cyclohexene oxide (CHO) as a solvent produced isotactic-enriched polylactide. The order of reactivities based on the metals supported by the TPP ligand is Cr(iii) > Al(iii) > In(iii) > Co(iii) while the reactivities of the catalysts supported by Cy-salen ligands are in the order In(iii) > Cr(iii) > Al(iii) > Co(iii).

A new route for the preparation of enriched iso-polylactide from rac-lactide via a Lewis acid catalyzed ring-opening of an epoxide.

Tetraphenylporphyrin aluminum(iii) salts, TPPAlX, where X = Me, OEt, OiPr, OCHMeCH2Cl, and Cl, and bis(triphenylphosphine)imminium chloride, PPN+Cl- (1 : 1) react with rac-lactide, rac-LA, in neat propylene oxide, PO, to yield chains of enriched isotactic polylactide, PLA, with end groups of PO-Cl and with time these yield cyclic polymers (PO)n(PLA) where n = 2 or 3 and even higher. There is no reaction between TPPAlOR (R = Et or iPr), PPN+Cl-, and rac-LA in neat THF at 25 °C even though TPPAlOR (R = Et or iPr) and PPN+Cl- in neat PO yields polypropylene oxide with a terminal OR group, H(PO)nOR. Taken together, Al(iii) acts as a Lewis acid in the ring-opening of PO, in which PPN+Cl- is present and the incipient ClCH2CHMeO- initiates the ROP of LA to yield anion chains of [(PLA)-OCHMeCH2Cl]-, and then the ring-opening of PO yields cycles, (PO)n(PLA), with the liberation of Cl-. The polymer was isolated by the addition of MeOH/HCl and end group analysis by mass spectrometry.